RxDoctor Payments Data

Courtney Jee, PA

Physician Assistant · Elk Grove, CANPI 1750843629

Payments from drug & device makers

$1,340in general payments, 2019–2025

Across 24 payments — averaging $55.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$927
  • Novo Nordisk$196
  • AstraZeneca$159
  • Esperion Therapeutics, Inc.$17
  • AbbVie$15
  • Biohaven Pharmaceutical Holding Company Ltd.$13
  • plus $12 from 1 others

What the payments were for

  • Consulting fees$80060%
  • Food & beverage$54040%

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,340 in reported general payments places this provider in the 75th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$52,541
Medicare patients
305
Services billed
514

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$33,268
JardianceEmpagliflozin18$20,650
Wixela InhubFluticasone Propion/Salmeterol28$2,328
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,621
Atorvastatin Calcium122$928
Gabapentin65$840
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$784
Famotidine50$761
Omeprazole67$621
Rosuvastatin Calcium28$548
Lisinopril62$540
Pregabalin15$535
Levothyroxine Sodium62$501
Fluticasone Propionate15$500
Albuterol Sulfate HfaAlbuterol Sulfate27$463

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$196$33,26828 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Elk Grove

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →